<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Thu May 07 00:54:39 UTC 2026 -->
<xs:schema xmlns:cvkd="http://www.cadrenal.com/20260331" elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2026" targetNamespace="http://www.cadrenal.com/20260331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2026" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cvkd-20260331_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cvkd-20260331_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cvkd-20260331_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="cvkd-20260331_cal.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef"/>
      <link:roleType roleURI="http://www.cadrenal.com/role/ConsolidatedBalanceSheet" id="cvkd_r_ConsolidatedBalanceSheet">
        <link:definition>995301 - Statement - Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ConsolidatedBalanceSheet_Parentheticals" id="cvkd_r_ConsolidatedBalanceSheet_Parentheticals">
        <link:definition>995302 - Statement - Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ConsolidatedComprehensiveIncome" id="cvkd_r_ConsolidatedComprehensiveIncome">
        <link:definition>995303 - Statement - Statements of Operations and Comprehensive Loss (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ShareholdersEquityType2or3" id="cvkd_r_ShareholdersEquityType2or3">
        <link:definition>995304 - Statement - Statements of Changes In Stockholders&#8217; Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ShareholdersEquityType2or3_Parentheticals" id="cvkd_r_ShareholdersEquityType2or3_Parentheticals">
        <link:definition>995305 - Statement - Statements of Changes In Stockholders&#8217; Equity (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ConsolidatedCashFlow" id="cvkd_r_ConsolidatedCashFlow">
        <link:definition>995306 - Statement - Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPolicies" id="cvkd_r_DescriptionofBusinessandSummaryofSignificantAccountingPolicies">
        <link:definition>995307 - Disclosure - Description of Business and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/RecentAccountingPronouncements" id="cvkd_r_RecentAccountingPronouncements">
        <link:definition>995308 - Disclosure - Recent Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/FairValueMeasurements" id="cvkd_r_FairValueMeasurements">
        <link:definition>995309 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/AccruedLiabilities" id="cvkd_r_AccruedLiabilities">
        <link:definition>995310 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/AssetPurchaseAgreement" id="cvkd_r_AssetPurchaseAgreement">
        <link:definition>995311 - Disclosure - Asset Purchase Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/StockholdersEquity" id="cvkd_r_StockholdersEquity">
        <link:definition>995312 - Disclosure - Stockholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/EquityBasedCompensation" id="cvkd_r_EquityBasedCompensation">
        <link:definition>995313 - Disclosure - Equity-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/NetLossPerShare" id="cvkd_r_NetLossPerShare">
        <link:definition>995314 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/LeasesCommitmentsandContingencies" id="cvkd_r_LeasesCommitmentsandContingencies">
        <link:definition>995315 - Disclosure - Leases, Commitments, and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/SubsequentEvents" id="cvkd_r_SubsequentEvents">
        <link:definition>995316 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/AccountingPoliciesByPolicy" id="cvkd_r_AccountingPoliciesByPolicy">
        <link:definition>996000 - Disclosure - Accounting Policies, by Policy (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/FairValueMeasurementsTables" id="cvkd_r_FairValueMeasurementsTables">
        <link:definition>996001 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/AccruedLiabilitiesTables" id="cvkd_r_AccruedLiabilitiesTables">
        <link:definition>996002 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/AssetPurchaseAgreementTables" id="cvkd_r_AssetPurchaseAgreementTables">
        <link:definition>996003 - Disclosure - Asset Purchase Agreement (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/StockholdersEquityTables" id="cvkd_r_StockholdersEquityTables">
        <link:definition>996004 - Disclosure - Stockholders&#8217; Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/EquityBasedCompensationTables" id="cvkd_r_EquityBasedCompensationTables">
        <link:definition>996005 - Disclosure - Equity-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/NetLossPerShareTables" id="cvkd_r_NetLossPerShareTables">
        <link:definition>996006 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/LeasesCommitmentsandContingenciesTables" id="cvkd_r_LeasesCommitmentsandContingenciesTables">
        <link:definition>996007 - Disclosure - Leases, Commitments, and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails" id="cvkd_r_DescriptionofBusinessandSummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996008 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsTable" id="cvkd_r_ScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsTable">
        <link:definition>996009 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofAccruedLiabilitiesTable" id="cvkd_r_ScheduleofAccruedLiabilitiesTable">
        <link:definition>996010 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/AssetPurchaseAgreementDetails" id="cvkd_r_AssetPurchaseAgreementDetails">
        <link:definition>996011 - Disclosure - Asset Purchase Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofDevelopmentMilestonesTable" id="cvkd_r_ScheduleofDevelopmentMilestonesTable">
        <link:definition>996012 - Disclosure - Asset Purchase Agreement - Schedule of Development Milestones (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofInitialPurchasePriceoftheAssetsAcquiredTable" id="cvkd_r_ScheduleofInitialPurchasePriceoftheAssetsAcquiredTable">
        <link:definition>996013 - Disclosure - Asset Purchase Agreement - Schedule of Initial Purchase Price of the Assets Acquired (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/StockholdersEquityDetails" id="cvkd_r_StockholdersEquityDetails">
        <link:definition>996014 - Disclosure - Stockholders&#8217; Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofTotalWarrantsOutstandingTable" id="cvkd_r_ScheduleofTotalWarrantsOutstandingTable">
        <link:definition>996015 - Disclosure - Stockholders&#8217; Equity - Schedule of Total Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/EquityBasedCompensationDetails" id="cvkd_r_EquityBasedCompensationDetails">
        <link:definition>996016 - Disclosure - Equity-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofAssumptionsUsedinBlackScholesModelTable" id="cvkd_r_ScheduleofAssumptionsUsedinBlackScholesModelTable">
        <link:definition>996017 - Disclosure - Equity-Based Compensation - Schedule of Assumptions Used in Black-Scholes Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofActivityUnderthePlansTable" id="cvkd_r_ScheduleofActivityUnderthePlansTable">
        <link:definition>996018 - Disclosure - Equity-Based Compensation - Schedule of Activity Under the Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofEquityBasedCompensationExpenseTable" id="cvkd_r_ScheduleofEquityBasedCompensationExpenseTable">
        <link:definition>996019 - Disclosure - Equity-Based Compensation - Schedule of Equity-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofEquityBasedCompensationExpenseTable0" id="cvkd_r_ScheduleofEquityBasedCompensationExpenseTable0">
        <link:definition>996020 - Disclosure - Equity-Based Compensation - Schedule of Equity-Based Compensation Expense (Details) 0</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofBasicandDilutedNetLossPerCommonShareTable" id="cvkd_r_ScheduleofBasicandDilutedNetLossPerCommonShareTable">
        <link:definition>996021 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofCommonStockEquivalentswereExcludedfromtheCalculationofDilutedNetLossPerShareTable" id="cvkd_r_ScheduleofCommonStockEquivalentswereExcludedfromtheCalculationofDilutedNetLossPerShareTable">
        <link:definition>996022 - Disclosure - Net Loss Per Share - Schedule of Common Stock Equivalents were Excluded from the Calculation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/LeasesCommitmentsandContingenciesDetails" id="cvkd_r_LeasesCommitmentsandContingenciesDetails">
        <link:definition>996023 - Disclosure - Leases, Commitments, and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/ScheduleofFutureAnnualLeasePaymentsUnderNonCancellableOperatingLeasesTable" id="cvkd_r_ScheduleofFutureAnnualLeasePaymentsUnderNonCancellableOperatingLeasesTable">
        <link:definition>996024 - Disclosure - Leases, Commitments, and Contingencies - Schedule of Future Annual Lease Payments Under Non-Cancellable Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/SubsequentEventsDetails" id="cvkd_r_SubsequentEventsDetails">
        <link:definition>996025 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.cadrenal.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2026" schemaLocation="https://xbrl.sec.gov/sic/2026/sic-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-sub-2026.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-sub-2026.xsd"/>
  <xs:element name="ScheduleOfFinancialAssetsAndLiabilitiesSubjectToFairValueMeasurementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfFinancialAssetsAndLiabilitiesSubjectToFairValueMeasurementsAbstract"/>
  <xs:element name="ScheduleOfDevelopmentMilestonesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfDevelopmentMilestonesAbstract"/>
  <xs:element name="ScheduleOfInitialPurchasePriceOfTheAssetsAcquiredAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfInitialPurchasePriceOfTheAssetsAcquiredAbstract"/>
  <xs:element name="ScheduleOfTotalWarrantsOutstandingAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfTotalWarrantsOutstandingAbstract"/>
  <xs:element name="ScheduleOfAssumptionsUsedInBlackScholesModelAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfAssumptionsUsedInBlackScholesModelAbstract"/>
  <xs:element name="ScheduleOfEquityBasedCompensationExpenseAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfEquityBasedCompensationExpenseAbstract"/>
  <xs:element name="ScheduleOfBasicAndDilutedNetLossPerCommonShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfBasicAndDilutedNetLossPerCommonShareAbstract"/>
  <xs:element name="ScheduleOfCommonStockEquivalentsWereExcludedFromTheCalculationOfDilutedNetLossPerShareAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfCommonStockEquivalentsWereExcludedFromTheCalculationOfDilutedNetLossPerShareAbstract"/>
  <xs:element name="LeasesCommitmentsAndContingenciesTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_LeasesCommitmentsAndContingenciesTextBlock"/>
  <xs:element name="LiquidityPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_LiquidityPolicyTextBlock"/>
  <xs:element name="EmergingGrowthCompanyStatusPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_EmergingGrowthCompanyStatusPolicyTextBlock"/>
  <xs:element name="DeferredOfferingCostsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_DeferredOfferingCostsPolicyTextBlock"/>
  <xs:element name="AcquisitionsPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_AcquisitionsPolicyTextBlock"/>
  <xs:element name="PatentPolicyTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PatentPolicyTextBlock"/>
  <xs:element name="ScheduleOfDevelopmentMilestonesTableTextBlock" type="dtr:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ScheduleOfDevelopmentMilestonesTableTextBlock"/>
  <xs:element name="FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_FairValueMeasurementsScheduleofFinancialAssetsandLiabilitiesSubjecttoFairValueMeasurementsDetailsTable"/>
  <xs:element name="AccruedResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_AccruedResearchAndDevelopment"/>
  <xs:element name="AssetPurchaseAgreementScheduleofDevelopmentMilestonesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_AssetPurchaseAgreementScheduleofDevelopmentMilestonesDetailsTable"/>
  <xs:element name="AssetPurchaseAgreementScheduleofDevelopmentMilestonesDetailsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_AssetPurchaseAgreementScheduleofDevelopmentMilestonesDetailsLineItems"/>
  <xs:element name="PaymentsOfMilestones" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PaymentsOfMilestones"/>
  <xs:element name="AssetAcquisitionConsiderationTransferredInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_AssetAcquisitionConsiderationTransferredInProcessResearchAndDevelopment"/>
  <xs:element name="ClassOfWarrantOrRightIssueDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ClassOfWarrantOrRightIssueDate"/>
  <xs:element name="ClassOfWarrantOrRightExpirationDate" type="xbrli:stringItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ClassOfWarrantOrRightExpirationDate"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised"/>
  <xs:element name="EquityBasedCompensationScheduleofAssumptionsUsedinBlackScholesModelDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_EquityBasedCompensationScheduleofAssumptionsUsedinBlackScholesModelDetailsTable"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted"/>
  <xs:element name="StockIssuedDuringPeriodSharesStockOptionExercised" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_StockIssuedDuringPeriodSharesStockOptionExercised"/>
  <xs:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledForfeitedExpired" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledForfeitedExpired"/>
  <xs:element name="WorkingsCapital" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_WorkingsCapital"/>
  <xs:element name="PercentageOfUncertainIncomeTaxPosition" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PercentageOfUncertainIncomeTaxPosition"/>
  <xs:element name="AssetPurchaseAgreementDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_AssetPurchaseAgreementDetailsTable"/>
  <xs:element name="SellerRoyaltiesPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_SellerRoyaltiesPercentage"/>
  <xs:element name="RoyaltyRevenueReceived" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_RoyaltyRevenueReceived"/>
  <xs:element name="StockholdersEquityDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_StockholdersEquityDetailsTable"/>
  <xs:element name="TotalGrossProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_TotalGrossProceeds"/>
  <xs:element name="NetProceeds" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" xbrli:balance="debit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_NetProceeds"/>
  <xs:element name="EquityBasedCompensationDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_EquityBasedCompensationDetailsTable"/>
  <xs:element name="MaximumNumberOfSharesOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_MaximumNumberOfSharesOfCommonStock"/>
  <xs:element name="CalendarYear" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_CalendarYear"/>
  <xs:element name="CommonStockOutstandingPercentage" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_CommonStockOutstandingPercentage"/>
  <xs:element name="ReservedSharesOfCommonStockAvailableForIssuance" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ReservedSharesOfCommonStockAvailableForIssuance"/>
  <xs:element name="RemainedAvailableSharesForFutureIssuance" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_RemainedAvailableSharesForFutureIssuance"/>
  <xs:element name="LeasesCommitmentsandContingenciesDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_LeasesCommitmentsandContingenciesDetailsTable"/>
  <xs:element name="SubsequentEventsDetailsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrldt:hypercubeItem" id="cvkd_SubsequentEventsDetailsTable"/>
  <xs:element name="PurchaseSharesOfCommonStock" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PurchaseSharesOfCommonStock"/>
  <xs:element name="TermOfWarrantsExercisable" type="xbrli:durationItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_TermOfWarrantsExercisable"/>
  <xs:element name="PercentageOfCashFee" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PercentageOfCashFee"/>
  <xs:element name="PercentageOfExercisePriceOfNewWarrants" type="dtr:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PercentageOfExercisePriceOfNewWarrants"/>
  <xs:element name="StockholdersEquityRequirement" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" xbrli:balance="credit" nillable="true" substitutionGroup="xbrli:item" id="cvkd_StockholdersEquityRequirement"/>
  <xs:element name="AssetPurchaseAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_AssetPurchaseAgreementMember"/>
  <xs:element name="ExistingWarrantSharesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ExistingWarrantSharesMember"/>
  <xs:element name="ExistingWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_ExistingWarrantsMember"/>
  <xs:element name="FDAApprovalOfNewDrugApplicationForFrunexianOrEP7327Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FDAApprovalOfNewDrugApplicationForFrunexianOrEP7327Member"/>
  <xs:element name="FirstPatientDosedInPhase1InitiatedWithEP7327Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FirstPatientDosedInPhase1InitiatedWithEP7327Member"/>
  <xs:element name="FirstPatientDosedInPhase2InitiatedWithFrunexianOrEP7327Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FirstPatientDosedInPhase2InitiatedWithFrunexianOrEP7327Member"/>
  <xs:element name="FirstPatientDosedInPhase3InitiatedWithFrunexianOrEP7327Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FirstPatientDosedInPhase3InitiatedWithFrunexianOrEP7327Member"/>
  <xs:element name="FirstPatientDosedInTheFirstClinicalTrialWithCAD1005Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FirstPatientDosedInTheFirstClinicalTrialWithCAD1005Member"/>
  <xs:element name="FirstRegulatoryFilingApprovalToMarketAProductOutsideTheUnitedStatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FirstRegulatoryFilingApprovalToMarketAProductOutsideTheUnitedStatesMember"/>
  <xs:element name="FirstUSFDAApprovalForSellerPatentedVeriloxProductMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_FirstUSFDAApprovalForSellerPatentedVeriloxProductMember"/>
  <xs:element name="HaiscoLicensingAgreementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_HaiscoLicensingAgreementMember"/>
  <xs:element name="InvestorWarrants2025Member" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_InvestorWarrants2025Member"/>
  <xs:element name="NewSeriesA1WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_NewSeriesA1WarrantsMember"/>
  <xs:element name="NewSeriesA2WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_NewSeriesA2WarrantsMember"/>
  <xs:element name="NewWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_NewWarrantsMember"/>
  <xs:element name="PlacementAgentWarrantOneMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PlacementAgentWarrantOneMember"/>
  <xs:element name="PlacementAgentWarrantsFourMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PlacementAgentWarrantsFourMember"/>
  <xs:element name="PlacementAgentWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PlacementAgentWarrantsMember"/>
  <xs:element name="PlacementAgentWarrantsThreeMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PlacementAgentWarrantsThreeMember"/>
  <xs:element name="PlacementAgentWarrantsTwoMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_PlacementAgentWarrantsTwoMember"/>
  <xs:element name="RegulatoryFilingApprovalToMarketAProductForASubsequentIndicationInTheUnitedStatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_RegulatoryFilingApprovalToMarketAProductForASubsequentIndicationInTheUnitedStatesMember"/>
  <xs:element name="RegulatoryFilingApprovalToMarketAProductForASubsequentIndicationOutsideTheUnitedStatesMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_RegulatoryFilingApprovalToMarketAProductForASubsequentIndicationOutsideTheUnitedStatesMember"/>
  <xs:element name="RepresentativeWarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_RepresentativeWarrantsMember"/>
  <xs:element name="SeriesA1WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_SeriesA1WarrantsMember"/>
  <xs:element name="SeriesB1WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_SeriesB1WarrantsMember"/>
  <xs:element name="SeriesB2WarrantsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_SeriesB2WarrantsMember"/>
  <xs:element name="TwentyTwentyFiveCommonStockMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_TwentyTwentyFiveCommonStockMember"/>
  <xs:element name="TwoThousandTwentyTwoPlanMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_TwoThousandTwentyTwoPlanMember"/>
  <xs:element name="VeraloxAPAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_VeraloxAPAMember"/>
  <xs:element name="VeraloxTherapeuticsIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_VeraloxTherapeuticsIncMember"/>
  <xs:element name="WarrantInducementMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_WarrantInducementMember"/>
  <xs:element name="eXItheraAPAMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_eXItheraAPAMember"/>
  <xs:element name="eXItheraPharmaceuticalsIncMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_eXItheraPharmaceuticalsIncMember"/>
<!-- [WMV7][c4Ir7NWl5kArIZDFzlTNxB0TLI2h4x7Lp27LJh5JStx+3FHHHNMGecQ7Rd1ZRWfKMcrLTE0XxZTowTqGbFArmkC/KHOixGuq6iDkZj8I7gOQ9vZTSIraggICObMNV6FH7BqnWVg0jiA7V4jmgcrCm0ZUxSEvUDEo/MLtEMzcijtAX0XIYn6avZ2cJJIb+dPAXFOFgpRtvgoI9CV17GEVZzXDMoiiBjNFeooxpPScusRJprtZAVXTZ9lQtw6ENbeyxtvKVeyfKHlFTbySr1SBlfG14VvEZyOVlz5c3RWKlyWBcD8QuduDZNMTdrU9ZVztgQWVEdrwmDw0y3uA1i/9eHtvqSjH6DRKoXRsi4z5mvfG5hDwaA==] CSR-->
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="cvkd_DocumentAndEntityInformationAbstract"/>
</xs:schema>
